Clinical trial
Radiation Therapy, Irinotecan, and Cetuximab in Treating Patients Who Are…
NCT00392470 · Centre Hospitalier Universitaire Vaudois, Other · Unknown status
Key facts
| NCT number | NCT00392470 |
|---|---|
| Title | Radiation Therapy, Irinotecan, and Cetuximab in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Rectal Cancer |
| Official title | Neoadjuvant Conformal Radiotherapy and Concomitant CPT-11 and EGFR Inhibition With Cetuximab in Patients With Rectal Cancer Phase I Study |
| Lead sponsor | Centre Hospitalier Universitaire Vaudois, Other |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | cetuximab, irinotecan hydrochloride, conventional surgery, neoadjuvant therapy, 3-dimensional conformal radiation therapy, intensity-modulated radiation therapy |
| Enrollment | 20 |
| Start date | Aug 1, 2006 |
| First posted | Oct 26, 2006 |
| Last update posted | May 25, 2011 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: